Estimation of the Percentage of US Patients With Cancer Who Are Eligible for and Respond to Checkpoint Inhibitor Immunotherapy Drugs

Alyson Haslam, Vinay Prasad

Research output: Contribution to journalArticle

Fingerprint Dive into the research topics of 'Estimation of the Percentage of US Patients With Cancer Who Are Eligible for and Respond to Checkpoint Inhibitor Immunotherapy Drugs'. Together they form a unique fingerprint.

Medicine & Life Sciences